Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.3700 (5.6%) ($5.3700 - $5.3700) on Fri. Jun. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.59% (three month average) | RSI | 85 | Latest Price | $5.3700(5.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 4.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLU(16%) XLRE(51%) SKYY(34%) SLV(11%) XLC(5%) | Factors Impacting CAPR price | CAPR will decline at least -2.295% in a week (0% probabilities). IFRA(-92%) IYT(-69%) IWD(-48%) IWN(-28%) IWM(-21%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.295% (StdDev 4.59%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.79(12.11%) | 10 Day Moving Average | $4.62(16.23%) | 20 Day Moving Average | $4.23(26.95%) | To recent high | 0% | To recent low | 6.8% | Market Cap | $106m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |